Biography
Mark Stuntz has joined Deerfield Institute in 2015 as an Epidemiology Senior Research Associate, responsible for evaluating and modeling epidemiological aspects of various diseases. Prior to joining Deerfield, he was as an Epidemiologist at Global Data where he developed ten year country-specific forecast models and reports for multiple indications including prostate cancer, methicillin-resistant Staphylococcus aureus (MRSA) and gram-negative bacterial urinary tract infections. He holds a Master of Public Health degree from the Yale School of Public Health with a concentration in Epidemiology of Microbial Diseases.
Abstract
Objectives: To estimate the prevalence of status epilepticus (SE), refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE) in the United States using an incidence-survival model. Methods: Yearly survival data for each SE etiology (acute symptomatic, progressive symptomatic, remote symptomatic and idiopathic/cryptogenic) were extracted from published research. Incident cases were calculated for each year using published rates. Applying the survival proportions and incidence estimates to the model for each etiology, we calculated an overall estimate of the prevalence of SE. RSE and SRSE prevalent cases were assessed as proportions of the total number of prevalent SE cases using published values. Results: The prevalence of SE was 17.6 cases per 10,000 population in the United States resulting in 566,241 cases in 2015 and increasing to 606,004 in 2024. The prevalence of RSE was 4.3 per 10,000 resulting in 139,295 cases in 2015, increasing to 149,077 in 2024. SRSE prevalence was 1.8 per 10,000 resulting in 56,624 cases in 2015, increasing to 60,600 in 2024. Conclusions: To our knowledge, this is the first attempt to calculate the prevalence of SE and its subtypes for all ages in the United States. Estimating the prevalence of SE, RSE and SRSE using population-based epidemiological methods is challenging because of the unpredictable nature of associated mortality. Our incidence-survival model provides an alternative and effective method to assess the prevalent population. Considering the high costs associated with treatment and hospitalization, prevalence estimates are necessary to quantify the burden of SE and its subtypes in the United States.
Biography
Jacquelin R Arguello is currently in her 4th year of Undergraduate Education (BS in Neurobiology/Physiology) at University of Maryland, College Park. She is interned at Mid-Atlantic Epilepsy & Sleep Center participating in research studies and patient care from February 2013-present. She is currently interning at a multispecialty office at Holy Cross Hospital.
Abstract
Rationale: The number of respective surgeries for patients with refractory epilepsy in the US may be declining. Reasons for this are not clear. One suggested explanation has been that respective surgeries are being done in non-academic centers and therefore are not being registered in academic center-based studies. The purpose of this study was to evaluate this hypothesis. Methods: Charts were reviewed of all newly-evaluated patients seen in one private epilepsy center during a three year period from 6/1/2010-5/31/2013. Results: 699 patients were evaluated (F=389, M=310, mean age 46 range 14-93). Of these, 537 had focal epilepsy. 355/537 (66.1%) of patients with focal epilepsy had pharmacoresistant epilepsy. 110/355 (31.0%) of these patients were admitted to EMU for long term video EEG monitoring. 64 of these patients had unifocal, 22 multifocal and 20 had non-localizable or non-lateralizable findings ictal EEG abnormalities; 4/120 had normal LTVEEGs. Of the 64 patients with unifocal EEG findings, 44 were temporal, 12 were frontal, 4 were parietal and 2 were occipital. Of the unifocal temporal EEG abnormalities, 22 were right sided and 22 were left sided. 11/64 of the patients with unifocal EEG abnormalities agreed to further surgical evaluation and underwent further pre-surgical testing. 4/11 failed pre-surgical work up (3 because of failed pre-surgical memory evaluation, one for language lateralization). 7 patients underwent surgical resection. Conclusion: The number of respective surgeries done at a private epilepsy center is not high. It is unlikely that shift of surgeries from academic to private epilepsy centers explains the decline in respective surgeries noticed by academic epilepsy centers.